Reportlinker.com

Reportlinker.com

April 16, 2008 05:02 ET

High Growth Forecasted for the Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

LONDON, UNITED KINGDOM--(Marketwire - April 16, 2008) - Reportlinker.com announces that a new market research report related to the Infectiou industry is available in its catalogue.

The Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

http://www.reportlinker.com/p087186/The-Vaccines-2008-World-Market-Analysis-Key-Players-and-Critical-Trends-in-a-Fast-Changing-Industry.html

Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has in 2007 and 2008. Since Kalorama Information last updated Kalorama Information's The World Market for Vaccines in the first quarter of last year, new products and better than expected profits have transformed the vaccine marketplace. Approvals that have been granted for products such as RotaTeq, Pentacel, Adacel and Zostavax and FluMist are now impacting the market. The launch and execution of the first successful cancer vaccine product, Merck's Gardasil, has had dramatic and surprising results. Other products also exceeded revenue expectations. The competitive dynamics have changed with merger activity, and many new products are on the way.

Kalorama vaccine market analyst Allison Sahoo's exhaustive research and analysis of interviews with key decision makers in the market includes the following:

- Review of Products in the Market

- Current World Market Size for Pediatric and Adult Vaccines

- Segmented Revenues and Forecasts to 2013 by Category

- Over 45 Charts and Tables To Make Information Accessible

- Important Vaccines and Immunization Schedules and Statistics

- Discussion of Issues and Trends in the Vaccine Market

- Profiles of 15 Key Vaccine Companies

- Thorough Review of the Vaccine Pipeline and Possible Impact of New Products

Who are the main players in the vaccine market? What opportunities are available for pharmaceutical companies or investors from this market? What are the potential challenges vaccine competitors must deal with? What will be the impact of the first successful cancer product? What is the significance of at least one major acquisition to affect this industry? These questions and more are tackled in this report.

Current revenues and revenue forecasts to 2013 are included for the following pediatric vaccine categories:

- DTaP & DTP Vaccines

- Hep Vaccines

- HiB Vaccines

- MMR Vaccines

- Combination Vaccines

- Pneumococcal Vaccines

- Polio Vaccines

- Varicella Vaccines

- Other Pediatric Vaccines

As well as Revenues and Forecasts to 2012 for the following adult vaccine categories:

- Influenza Vaccines

- Hepatitis Vaccines

- Pneumococcal Vaccines

- Travel, DT and other Adult Vaccines

- Cervical Cancer

This is a rapidly changing marketplace and knowledge of the R&D pipeline is essential to truly understand what is happening in vaccines. Vaccines in development are discussed in this report, including vaccines for the following conditions:

- Enterotoxigenic Escherichia coli

- Parainfluenza Virus Type 3

- Pneumococcal Vaccines

- Respiratory Syncytial Virus less than

- Cancers

- Cholera

- HIV/AIDS

- Helicobacter Pylori

- Malaria

- Rabies

- Tuberculosis

- West Nile Virus

This Kalorama Information report was created with a primary research effort - interviews with market experts in the vaccine market who shared insights, informed of new trends and helped to construct models, supplemented by secondary research in company, medical and trade literature. Marketing and Business Development executives, strategic planners, research and development executives, as well as investors and financial consultants are among those who will find this a useful resource.

CHAPTER ONE: EXECUTIVE SUMMARY

The Global Vaccine Industry

Scope And Methodology

Overview

Pediatric Preventative Vaccines

The Market

Adult Preventative Vaccines

The Market

Total Vaccine Market

Issues and Trends

A "Gardasil Effect" in R&D?

CHAPTER TWO: INTRODUCTION TO VACCINES

A Brief History: The Development of Vaccines

The Immune Response

Mechanism of Action

Types of Vaccines

Attenuated (Weakened) Live Viruses

Killed (Inactivated) Viruses

Toxoid Vaccines

Genetically Engineered/Modified Vaccines

Subunit Vaccines

Conjugate Vaccines

DNA Vaccination

Vaccine Approval Process

CHAPTER THREE: PEDIATRIC VACCINES

Introduction

Childhood Immunization in the United States

Childhood Immunization Rates

Challenges to the Vaccine Delivery System

Recommended Childhood Immunization Schedule

State Immunization Recommendations

Pediatric Vaccine Products

BCG Vaccines

Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio Vaccines

Diphtheria

Pertussis

Tetanus

Hepatitis B

Poliomyelitis

Haemophilus Influenzae Type B Vaccines

Hepatitis A Vaccines

Measles, Mumps and Rubella Vaccines

Measles

Mumps

Rubella

Pneumococcal Conjugate Vaccine

Rotavirus Vaccines

Varicella Vaccines

Meningococcal Vaccines

Cost of Vaccines in the United States

Pediatric Vaccines in Development

Global Initiatives for Vaccine Research

Enterotoxigenic Escherichia coli

Parainfluenza Virus Type 3

Pneumococcal Vaccines

Respiratory Syncytial Virus

The World Market for Pediatric Preventive Vaccines

Total Market Size and Forecast

DTP and DTaP Vaccine Market

Market Analysis

Leading Products and Competitors

Hepatitis Vaccine Market

Market Analysis

Leading Products and Competitors

Haemophilus Influenzae Type B Vaccine Market

Market Analysis

Leading Products and Competitors

Measles, Mumps and Rubella Vaccines

Market Analysis

Combination Vaccines Market

Market Analysis

Leading Products and Competitors

Pneumococcal Vaccine

Leading Products and Competitors

Poliovirus Vaccine

Market Analysis

Leading Products and Competitors

Varicella Vaccines

Market Analysis

Leading Products and Competitors

Other Vaccines Market

Market Analysis

Leading Products and Competitors

CHAPTER FOUR: ADULT PREVENTIVE VACCINES

Introduction

Adult Vaccine-Preventable Diseases: Facts and Figures

Global Virological Surveillance Program

Recommendations for Adult Immunizations

WHO International Health Regulations

Adult Vaccine Products

BCG Vaccines

Cervical Cancer Vaccines

Cholera Vaccines

Diphtheria-Tetanus Vaccines

Hepatitis Vaccines

Hepatitis A

Hepatitis B

Influenza Vaccines

Japanese Encephalitis Vaccines

Pneumococcal Disease Vaccines

Rabies Vaccines

Shingles Vaccine

Typhoid Vaccines

Yellow Fever Vaccines

Adult Vaccines in Development

Global Initiatives for Vaccine Research

Cancer

Cholera

HIV/AIDS

Helicobacter Pylori

Hepatitis

Hepatitis B

Hepatitis C

Hepatitis E

Herpesvirus

Influenza

Leishmaniasis

Malaria

Rabies

Tuberculosis

Typhoid Fever

West Nile Virus

The World Market for Adult Preventive Vaccines

Total Market Size and Forecast

Cervical Cancer Market

Market Analysis

Leading Products and Competitors

Hepatitis Market

Market Analysis

Leading Products and Competitors

Influenza Vaccine Market

Market Analysis

Leading Products and Competitors

Market Analysis

Leading Products and Competitors

Travel, DT, and Miscellaneous Vaccine Market

Market Analysis

Leading Products and Competitors

CHAPTER FIVE: VACCINES MARKET SUMMARY

Trends Driving the Vaccines Market

Market Size and Forecast

Vaccine Market Competitors

Pediatric Vaccines

Major Manufacturer's Market Share

Adult Vaccines

Major Manufacturer's Market Share

CHAPTER SIX: ISSUES AND TRENDS

Resistance to Immunization

Vaccine Safety

Vaccine Adverse Event Reporting System

The Vaccine Safety Datalink Project

The Vaccine Injury Compensation Program

Increased US Vaccine Availability

Vaccine Shortages

Preventing Shortages in the Developed Countries

A 'Gardasil Effect' in R&D?

Vaccines and Bioterrorism

Overview

Project Bioshield Act of 2004

National Bio and Agro-Defense Facility

Vaccine Treatment and Evaluation Units

Anthrax

Smallpox

Plague

Botulism

Tularemia

Viral Hemorrhagic Fevers

DNA Vaccination

Innovations in Vaccine Delivery Systems

Edible Vaccines

Mucosal Delivery

Intranasal Delivery

Oral Vaccines

Vaccine Patches

CHAPTER SEVEN: COMPANY PROFILES

Acambis plc

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

AlphaVax, Inc.

History and Lines of Business

Strategic Alliances

Vaccine Products

Avant Immunotherapeutics

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Bavarian Nordic A/S

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Baxter Healthcare

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Crucell

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Emergent biosolutions

History and Lines of Business

Strategic Acquisition and Alliance

Vaccine Products

Financial

GlaxoSmithKline

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Medimmune

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Merck & Co. Inc

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Nabi Biopharmaceuticals

History and Lines of Business

Strategic Alliance

Vaccine Products

Financial Information

Novartis

History and Lines of Business

Strategic Alliances

Vaccine Products

Pfizer

History and Lines of Business

Strategic alliances

Vaccine products

Financial Information

Pharmexa

History and Lines of Business

Strategic alliances

Vaccine Products

Financial Information

Sanofi Pasteur

History and Lines of Business

Strategic Alliances

Vaccine Products

Financial Information

Wyeth

History and Lines of Business

Vaccine Products

Financial Information

APPENDIX: COMPANY DIRECTORY

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Figure 1-1: World Market for Pediatric Vaccines 2004-2013 Revenues

Figure 1-2: World Market for Adult Vaccines 2004-2013 Revenues

CHAPTER TWO: INTRODUCTION TO VACCINES

Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2006

Table 2-2: Vaccine-Preventable Diseases, April 2008

CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES

Table 3-1: Global Immunization Rates by Vaccine Type 2006

Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 2000-2006

Table 3-3: U.S. Recommended Childhood Immunization Schedule, 2008

Table 3-4: U.S. Recommended Adolescent Immunization Schedule, 2008

Table 3-5: Selected Pediatric Vaccines in Development, April 2008

Table 3-6: World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others) 2004-2013

Figure 3-1: Market Share of Pediatric Vaccines by Type 2007

Figure 3-2: Market Share of Pediatric Vaccines, by Type 2013

Table 3-7: World DTP and DTaP Vaccine Market 2004-2013

Table 3-8: World Pediatric Hepatitis Vaccine Market 2004-2013

Table 3-9: World Hib Vaccine Market, 2004-2013

Table 3-10: World MMR Vaccines Market 2004-2013

Table 3-11: World Combination Vaccines Market 2004-2013

Table 3-12: World Pediatric Pneumococcal Vaccine Market 2004-2013

Table 3-13: World Poliovirus Vaccine Market 2004-2013

Table 3-14: World Varicella Vaccine Market 2004-2013

Table 3-15: Other Vaccines Market 2004-2013

CHAPTER FOUR: ADULT PREVENTIVE VACCINES

Table 4-1: Universal Adult Immunization Schedule 2008

Table 4-2: Adult Immunization Schedule for Populations with Special Medical Conditions, 2008

Table 4-3: Initiatives to Require HPV Vaccination by U.S. State, 2008

Table 4-4: Selected Adult Preventive Vaccines in Development, 2008

Table 4-5: World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2004-2013

Figure 4-1: Market Share of Adult Vaccines, by Type, 2007 (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel)

Figure 4-2: Market Share of Adult Vaccines, by Type, 2013

Table 4-6: World Cervical CancerVaccine Market 2004-2013

Table 4-7: World Hepatitis Vaccine Market 2004-2014

Table 4-8: World Influenza Vaccine Market 2004-2013

Table 4-9: CDC Goal to Double Flu Immunization by 2010 Group and Estimated Immunization Rate (2000 vs 2010)

Table 4-10: 2007 Estimated Population by Region and Selected Age Group

Table 4-11: World Pneumococcal Vaccine Market 2004-2013

Table 4-12: World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2004-2013

CHAPTER FIVE: VACCINES MARKET SUMMARY

Table 5-1: The World Vaccines Market by Vaccine Type 2004-2013

Figure 5-1: World Market for Vaccines by Type 2004-2013

Figure 5-2: World Market for Vaccines Share by Type, 2004, 2007 and 2013

Table 5-2: Major Manufacturers' Shares of the World Vaccine Market, 2007 154 Figure 5-3: 2007 World Vaccines Market Share, by Leading Competitors 155 Table 5-3: Major Manufacturer's Shares of the World Pediatric Vaccine Market 2007

Figure 5-5: Market Share of Pediatric Vaccines Market, 2007 157 Table 5-4: Major Manufacturer's Shares of the World Adult Vaccine Market 2007

Figure 5-6: Market Share of Adult Vaccines Market 2007

CHAPTER SIX: ISSUES AND TRENDS

Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines

To order this report:

The Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

http://www.reportlinker.com/p087186/The-Vaccines-2008-World-Market-Analysis-Key-Players-and-Critical-Trends-in-a-Fast-Changing-Industry.html

More market research reports here!

Contact Information